Inhibition of mouse breast adenocarcinoma growth by ablation with intratumoral alpha-irradiation combined with inhibitors of immunosuppression and CpG Hila ConfinoMichael SchmidtYona Keisari Original Article 06 August 2016 Pages: 1149 - 1158
Inhibition of HIF-1α enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancer Nasim KheshtchinSamaneh ArabJamshid Hadjati Original Article 06 August 2016 Pages: 1159 - 1167
The HB22.7–vcMMAE antibody–drug conjugate has efficacy against non-Hodgkin lymphoma mouse xenografts with minimal systemic toxicity Mastewal AbuhayJason KatoJoseph M. Tuscano Original Article 09 August 2016 Pages: 1169 - 1175
Identification of a naturally processed HLA-A*02:01-restricted CTL epitope from the human tumor-associated antigen Nectin-4 Marc LopezAbderrezak GhidoucheDaniel Olive Original Article 11 August 2016 Pages: 1177 - 1188
Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases Ileana S. MauldinNolan A. WagesCraig L. Slingluff Jr. Original Article 13 August 2016 Pages: 1189 - 1199
Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases Ileana S. MauldinNolan A. WagesCraig L. Slingluff Jr. Original Article 13 August 2016 Pages: 1201 - 1212
Prognostic significance of HLA class I and II expression in patients with diffuse large B cell lymphoma treated with standard chemoimmunotherapy Kohei TadaAkiko Miyagi MaeshimaYukio Kobayashi Original Article 13 August 2016 Pages: 1213 - 1222
Immunological evaluation of personalized peptide vaccination for patients with histologically unfavorable carcinoma of unknown primary site Shinjiro SakamotoShigeru YutaniMasanori Noguchi Original Article 22 August 2016 Pages: 1223 - 1231
A panel of autoantibodies against multiple tumor-associated antigens in the immunodiagnosis of esophageal squamous cell cancer Hong-Fei ZhangJie-Jie QinJian-Ying Zhang Original Article 23 August 2016 Pages: 1233 - 1242
4-1BB agonism: adding the accelerator to cancer immunotherapy Cariad ChesterSiddhant AmbulkarHolbrook E. Kohrt Focussed Research Review Open access 31 March 2016 Pages: 1243 - 1248
Opportunities for immunotherapy in microsatellite instable colorectal cancer Harm WestdorpFelix L. FennemannI. Jolanda M. de Vries Focussed Research Review Open access 08 April 2016 Pages: 1249 - 1259
Modulation of innate immunity in the tumor microenvironment Elena Gonzalez-GugelMansi SaxenaNina Bhardwaj Focussed Research Review 25 June 2016 Pages: 1261 - 1268
Concepts in glioma immunotherapy Michael PlattenLukas BunseTheresa Bunse Focussed Research Review 26 July 2016 Pages: 1269 - 1275
The right patient for the right therapy: 13th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 11–13, 2015 Matthias MillerVeronika JahndelBjörn-Philipp Kloke Meeting Report 03 June 2016 Pages: 1277 - 1287